Page last updated: 2024-08-23

pravastatin and Birth Weight

pravastatin has been researched along with Birth Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alijotas-Reig, J; Bonacina, E; Carreras, E; Ferrer-Oliveras, R; Garcia-Manau, P; Mendoza, M; Rodo, C1
Ahmed, MS; Brown, LM; Caritis, SN; Cleary, K; Costantine, MM; D'Alton, M; Easterling, TR; Haas, DM; Haneline, LS; Hankins, G; Hebert, MF; Ren, Z; Venkataramanan, R; West, H1

Trials

1 trial(s) available for pravastatin and Birth Weight

ArticleYear
Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:6

    Topics: Adult; Birth Weight; Cholesterol; Double-Blind Method; Female; Fetal Blood; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant, Newborn; Pilot Projects; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy, High-Risk

2016

Other Studies

1 other study(ies) available for pravastatin and Birth Weight

ArticleYear
Evaluating the Effect of Pravastatin in Early-Onset Fetal Growth Restriction: A Nonrandomized and Historically Controlled Pilot Study.
    American journal of perinatology, 2021, Volume: 38, Issue:14

    Topics: Biomarkers; Birth Weight; Female; Fetal Development; Fetal Growth Retardation; Historically Controlled Study; Humans; Infant, Newborn; Pilot Projects; Placenta Growth Factor; Pravastatin; Pregnancy; Pregnancy Outcome; Ultrasonography, Doppler; Ultrasonography, Prenatal; Vascular Endothelial Growth Factor Receptor-1

2021